Emergent BioSolutions (EBS) Tops Q1 EPS by 142c, provides guidanvce
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.16 +4.94%
Revenue Growth %: -45.6%
Financial Fact:
Other income (expense), net: -234K
Today's EPS Names:
ANAB, ANIX, MNY, More
Revenue Growth %: -45.6%
Financial Fact:
Other income (expense), net: -234K
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.59, $1.42 better than the analyst estimate of ($0.83). Revenue for the quarter came in at $300.4 million versus the consensus estimate of $185.4 million.
GUIDANCE:
Emergent BioSolutions sees FY2024 revenue of $1-1.1 billion, versus the consensus of $1.015 billion.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance
- Skillsoft (SKIL) Tops Q2 EPS by 14c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
